Table 2.

Multivariable logistic regression modelling for COVID-19 infection

Variable	Multivariable logistic regression (outcome: infection)
	Event vs. reference level	Odds ratio (95% CI)	p value	Omnibus p value
Female	Female vs. male	2.549 (0.641–10.13)	0.184
Immunotherapy group	–	–	–	0.253
Anti-CD20s, S1PRMs	Anti-CD20s, S1PRMs vs. Nil	1.840 (0.748–4.527)	0.193
DMARDs	DMARDs vs. Nil	0.611 (0.207–1.805)	0.065
IRTs	IRTs vs. Nil	1.688 (0.505–5.639)	0.489
Other DMTs	Other DMTs vs. Nil	1.561 (0.466–5.226)	0.604
Non-receipt of V3	Not received vs. received	4.377 (1.742–11.00)	0.002

Overall model p value = 0.0007. Model performance was assessed via Hosmer and Lemeshow goodness-of-fit test (p value = 0.949)

Anti-CD20s anti-CD20 therapies, DMARDs disease-modifying anti-rheumatic drugs, DMTs disease-modifying therapies, IRTs immune reconstitution therapies, S1PRMs sphingosine-1-phosphate receptor modulators, V3 third mRNA vaccination